Gene · 1856
Papers1,699
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
101 to 120 of 1,699
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Water extract of frankincense and myrrh inhibits liver cancer progression and epithelial‑mesenchymal transition through Wnt/β‑catenin signaling. | Mol Clin Oncol | 2023 | 37719039 | PubTator, text mining | PubMed |
| Rho family small GTPase Rif regulates Wnt5a-Ror1-Dvl2 signaling and promotes lung adenocarcinoma progression. | J Biol Chem | 2023 | 37703992 | PubTator, text mining | PubMed |
| Unlocking the potential of targeting histone-modifying enzymes for treating IBD and CRC. | Clin Epigenetics | 2023 | 37697409 | PubTator, text mining | PubMed |
| Endothelial APC/PAR1 distinctly regulates cytokine-induced pro-inflammatory VCAM-1 expression. | Front Mol Biosci | 2023 | 37692066 | PubTator, text mining | PubMed |
| Cx43 Facilitates Mesenchymal Transition of Endothelial Cells Induced by Shear Stress. | J Vasc Res | 2023 | 37673049 | PubTator, text mining | PubMed |
| Circular RNAs: novel actors of Wnt signaling pathway in lung cancer progression. | EXCLI J | 2023 | 37636026 | PubTator, text mining | PubMed |
| Amyloid Precursor Protein (APP) Regulates Gliogenesis and Neurogenesis of Human Neural Stem Cells by Several Signaling Pathways. | Int J Mol Sci | 2023 | 37629148 | PubTator, text mining | PubMed |
| Advances in treatment of alveolar soft part sarcoma: an updated review. | Jpn J Clin Oncol | 2023 | 37626447 | PubTator, text mining | PubMed |
| Potential roles of NEDD4 and NEDD4L and their utility as therapeutic targets in high‑incidence adult male cancers (Review). | Mol Clin Oncol | 2023 | 37614371 | PubTator, text mining | PubMed |
| Wnt3a signaling with serum supply induces replication stress in cultured cells. | Biochem Biophys Rep | 2023 | 37601449 | PubTator, text mining | PubMed |
| An interaction between OTULIN and SCRIB uncovers roles for linear ubiquitination in planar cell polarity. | Dis Model Mech | 2023 | 37589075 | PubTator, text mining | PubMed |
| Roles and Molecular Mechanisms of Biomarkers in Hepatocellular Carcinoma with Microvascular Invasion: A Review. | J Clin Transl Hepatol | 2023 | 37577231 | PubTator, text mining | PubMed |
| SF3B1 mutation-mediated sensitization to H3B-8800 splicing inhibitor in chronic lymphocytic leukemia. | Life Sci Alliance | 2023 | 37562845 | PubTator, text mining | PubMed |
| KITENIN promotes aerobic glycolysis through PKM2 induction by upregulating the c-Myc/hnRNPs axis in colorectal cancer. | Cell Biosci | 2023 | 37553596 | PubTator, text mining | PubMed |
| Immunologic Assessment of Tumors from a Race-matched Military Cohort Identifies Mast Cell Depletion as a Marker of Prostate Cancer Progression. | Cancer Res Commun | 2023 | 37534375 | PubTator, text mining | PubMed |
| Ehrlichia Wnt SLiM ligand mimic deactivates the Hippo pathway to engage the anti-apoptotic Yap-GLUT1-BCL-xL axis. | Infect Immun | 2023 | 37530530 | PubTator, text mining | PubMed |
| MiT family translocation renal cell carcinoma with retroperitoneal metastasis in childhood: a case report. | Front Pediatr | 2023 | 37528880 | PubTator, text mining | PubMed |
| Recent advances of exosomal circRNAs in cancer and their potential clinical applications. | J Transl Med | 2023 | 37525158 | PubTator, text mining | PubMed |
| Pathway selectivity in Frizzleds is achieved by conserved micro-switches defining pathway-determining, active conformations. | Nat Commun | 2023 | 37516754 | PubTator, text mining | PubMed |
| Cilia and Cancer: From Molecular Genetics to Therapeutic Strategies. | Genes (Basel) | 2023 | 37510333 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1856/papers?page=6